340B Contract Pharmacy Audits Double: HRSA Targets Compliance Gaps at FQHCs
HRSA has doubled 340B program audits targeting contract pharmacy arrangements, with 47 covered entities under review in Q1 2026. Common violations include duplicate discounts, inadequate patient eligibility verification, and missing contract pharmacy agreements.
FQHCs operating 340B programs must demonstrate real-time eligibility checks, split-billing compliance, and complete audit trails for every 340B transaction. Non-compliance can result in program repayment and suspension.
Key takeaways
- HRSA doubled 340B audits: 47 covered entities under review in Q1 2026
- Common violations: duplicate discounts, inadequate eligibility verification, missing pharmacy agreements
- Non-compliance: program repayment and suspension
- Action: demonstrate real-time eligibility checks, split-billing compliance, complete audit trails
Primary source
HRSA Office of Pharmacy AffairsFQHC Talent. (2026, February 15). 340B Contract Pharmacy Audits Double: HRSA Targets Compliance Gaps at FQHCs. Primary source: HRSA Office of Pharmacy Affairs. Retrieved June 12, 2026, from https://www.fqhctalent.com/intel/340b-audit-wave-contract-pharmacy-2026
More in Risk & Compliance
Jul 5
Section 1557 Language Access Annual Notice Year 1 Anniversary — July 5, 2026 Compliance Window
Jun 9
FTCA CY2027 redeeming applications due June 26 — miss it and your FQHC has a malpractice-coverage gap
Jun 1
Two Compliance Signals for FQHCs: HRSA's FY2026 340B Manufacturer-Audit Results Go Live, and OCR's Ransomware Settlements Preview a Tougher HIPAA Security Rule
Jun 1
Eli Lilly Gives ~50 Covered Entities Five Days to Hand Over 340B Claims Data — or Lose Their Discounts